Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 Nov;17(6):585-9.
doi: 10.1097/MOH.0b013e32833e7561.

Novel clearance mechanisms of platelets

Renata Grozovsky  1 , Karin M Hoffmeister, Hervé Falet
Affiliations
Review

Novel clearance mechanisms of platelets

Renata Grozovsky et al. Curr Opin Hematol. 2010 Nov.

Abstract

Purpose of review: Blood platelets are involved in primary and secondary hemostasis and thus maintain the integrity of the vasculature. They circulate with an average lifespan of 5-9 days in humans. Thus, the body must generate and clear platelets daily to maintain normal physiological blood platelet counts. Known platelet clearance mechanisms include antibody-mediated clearance by spleen macrophages, as in immune thrombocytopenia, and platelet consumption due to massive blood loss.

Recent findings: New concepts in the clearance mechanisms of platelets have recently emerged. New evidence shows that platelets desialyted due to chilling or sepsis are cleared in the liver by macrophages, that is Kupffer cells, as well as hepatocytes, through lectin-mediated recognition of platelet glycans. On the contrary, platelet-associated antibodies normalize the clearance of platelets in a mouse model for Wiskott-Aldrich syndrome.

Summary: The goal of this review is to summarize the latest findings in platelet clearance mechanisms with a focus on lectin-mediated recognition of platelet glycans. Transfusion medicine and treatments of hematopoietic disorders associated with severe thrombocytopenia may benefit from a better understanding of these mechanisms.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1. Platelet clearance pathways
Legend: Platelets bearing incomplete glycans are recognized by either liver macrophages or hepatocyte lectins, which leads to their clearance. IgG-coated platelets are phagocytized by both the Fc and complement receptors in the spleen. IgGs may recognize both amino acid and glycan residues. On the other hand, the binding of immune complexes, e.g. IgAs, to platelets prevents their rapid clearance.
See this image and copyright information in PMC

References

    1. Murphy S, Rebulla P, Bertolini F, et al. In vitro assessment of the quality of stored platelet concentrates. The BEST (Biomedical Excellence for Safer Transfusion) Task Force of the International Society of Blood Transfusion. Transfus Med Rev. 1994;8:29–36. - PubMed
    1. Stasi R, Evangelista ML, Stipa E, et al. Idiopathic thrombocytopenic purpura: current concepts in pathophysiology and management. Thromb Haemost. 2008;99:4–13. - PubMed
    1. McMillan R. The pathogenesis of chronic immune thrombocytopenic purpura. Semin Hematol. 2007;44:S3–S11. - PubMed

    1. Cines DB, Bussel JB, Liebman HA, Luning Prak ET. The ITP syndrome: pathogenic and clinical diversity. Blood. 2009;113:6511–6521. This review provides a detailed overview on ITP, highlighting its heterogeneity for a better understanding of diagnosis and management.

    1. Kuhne T, Buchanan GR, Zimmerman S, et al. Intercontinental Childhood ITPSG: A prospective comparative study of 2540 infants and children with newly diagnosed idiopathic thrombocytopenic purpura (ITP) from the Intercontinental Childhood ITP Study Group. J Pediatr. 2003;143:605–608. - PubMed

Publication types